Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2026-01-22 @ 9:16 AM
Study NCT ID:
NCT04324151
Status:
RECRUITING
Last Update Posted:
2024-09-19
First Post:
2020-03-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab Combined With Double Platinum Based Chemotherapy for Potentially Resectable NSCLC
Sponsor:
Hunan Province Tumor Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non Small Cell Lung Cancer | View |
Keywords: